NCT07216508Recruiting

Liver Transplant CGM

Icahn School of Medicine at Mount Sinai

Start Date

10/13/2025

Completion Date

10/5/2027

Summary

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Detailed Description

Liver transplant participants will be recruited. Participants will wear a blinded sensor after hospital discharge for up to 30 days. Data can be shared with participant and the providers retrospectively. Participants will be invited to wear another blinded sensor at 6 and 12 months.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: • inpatient liver transplant participants who have had an inpatient glucose greater than 180mg/dL Exclusion Criteria: * having a planned discharge to a rehabilitation or nursing facility, * a contraindication to sensor placement, * if discharge is anticipated to be \>30 days post-transplant, or * if recent transplant also included a kidney or pancreas transplant

Interventions

DEVICE

Libre 3+

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Liver TransplantPost Transplant DiabetesType 2 Diabetes

Locations

Mount Sinai Hospital

New York, New York 10029

United States